A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis
Clinical trial NCT05383378 · COMPLETED
Trial details
- NCT number
- NCT05383378
- Sponsor
- selectION Therapeutics GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-30
- Primary completion
- 2023-11-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.